Dey settles with Connecticut
Executive Summary
Dey settles Medicaid fraud claims with Connecticut and agrees to pay $900,000 over allegations of submitting false pricing information. The Napa, Calif.-based company also agrees to donate $800,000 worth of pharmaceuticals to Connecticut community health centers and clinics. Dey reached a settlement with Texas regarding a similar allegation in 2003 (1"The Pink Sheet" June 16, 2003, In Brief)...
You may also be interested in...
Dey will pay
Dey settles Medicaid fraud claims with U.S. and Texas and agrees to pay $18.5 mil. over charges of submitting false pricing information. Cases against Schering-Plough subsidiary Warrick and Boehringer Ingelheim subsidiary Roxane are scheduled to go to trial in August. The suits were based on information from a whistleblower (1"The Pink Sheet" Sept. 11, 2000, p. 10)...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.